Johnson & Johnson
CIK Number: 0000200406
Main Sectors:
Top Industries:
Filing Date: May 7, 2025
| Rank | Symbol | Name | Price | % Change | Shares | % Change Shares | Market Value | Avg. Price Paid | % Weight | Asset Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist The... | 56.19 | -7.17% | 2.45M | 0.00% | 118.44M | 17.72 | 34.65% | Share |
| 2 | CVRX | CVRx, Inc. | 7.95 | +1.66% | 4.1M | 0.00% | 50.18M | 16.75 | 14.68% | Share |
| 3 | MGTX | MeiraGTx Holdin... | 7.47 | -2.86% | 6.64M | 0.00% | 45.03M | 9.43 | 13.17% | Share |
| 4 | LEGN | Legend Biotech ... | 34.62 | -4.05% | 814.59K | 0.00% | 27.64M | 50.56 | 8.08% | Share |
| 5 | RAPP | Rapport Therape... | 31.47 | +119.15% | 2.5M | 0.00% | 25.06M | 25.44 | 7.33% | Share |
| 6 | PRCT | PROCEPT BioRobo... | 38.92 | -4.33% | 357.94K | 0.00% | 20.85M | 38.15 | 6.10% | Share |
| 7 | NBTX | Nanobiotix S.A. | 8.71 | +0.15% | 5.62M | 0.00% | 20.13M | 7.53 | 5.89% | Share |
| 8 | CTNM | Contineum Thera... | 12.13 | +5.48% | 1.98M | 0.00% | 13.81M | 21 | 4.04% | Share |
| 9 | XNCR | Xencor, Inc. | 8.41 | -1.64% | 748.06K | 0.00% | 7.96M | 40.12 | 2.33% | Share |
| 10 | ARWR | Arrowhead Pharm... | 27.17 | -6.55% | 247.6K | 0.00% | 3.15M | 62.43 | 0.92% | Share |
| 11 | FATE | Fate Therapeuti... | 0.97 | -4.36% | 3.38M | 0.00% | 2.67M | 59.27 | 0.78% | Share |
| 12 | RLYB | Rallybio Corpor... | 0.59 | -2.38% | 3.64M | 0.00% | 2.38M | 1.36 | 0.70% | Share |
| 13 | NMRA | Neumora Therape... | 1.66 | -1.19% | 1.85M | 0.00% | 1.85M | 15.6 | 0.54% | Share |
| 14 | NNOX | Nano-X Imaging ... | 4.02 | +8.94% | 158.85K | 0.00% | 793.47K | 11.1 | 0.23% | Share |
| 15 | VOR | Vor Biopharma I... | 1.98 | +1.02% | 1.07M | 0.00% | 771.07K | 15.68 | 0.23% | Share |
| 16 | LYEL | Lyell Immunopha... | 13.03 | +7.24% | 823.32K | 0.00% | 442.94K | 12.8 | 0.13% | Share |
| 17 | LAB | Standard BioToo... | 1.36 | +4.62% | 311.97K | 0.00% | 336.92K | 2.7 | 0.10% | Share |
| 18 | ACET | Adicet Bio, Inc... | 0.76 | +5.90% | 364.47K | 0.00% | 275.18K | 7.84 | 0.08% | Share |